As very little is known about the pathological role of afamin in pathological conditions, we hypothesized the evaluation of the association of afamin with renal parameters and cardiovascular health biomarkers, including the lipid profile, blood pressure, and CKD-MBD biomarkers, in various stages of CKD. Here, AFM is linked to Marchiafava-Bignami disease.